Medication used to treat heart failure recalled nationwide
Key takeaways
- Nearly 1 million bottles of Corlanor, known generically as ivabradine, are being recalled because they may contain a foreign substance, according to a Food and Drug Administration (FDA) recall alert.
- Corlanor is prescribed for adults with chronic heart failure to lower the risk of hospitalization due to worsening conditions.
- The recall, which affects at least 934,577 bottles containing 5 mg tablets of Corlanor manufactured in Italy, is being voluntarily initiated by Amgen, Inc., the manufacturer of the medication.
Why this matters: political developments that affect policy direction and public trust.
Nearly 1 million bottles of Corlanor, known generically as ivabradine, are being recalled because they may contain a foreign substance, according to a Food and Drug Administration (FDA) recall alert.
Corlanor is prescribed for adults with chronic heart failure to lower the risk of hospitalization due to worsening conditions. It is also used to treat children aged 6 months and older with stable heart failure symptoms caused by an enlarged heart, according to the Mayo Clinic.
The recall, which affects at least 934,577 bottles containing 5 mg tablets of Corlanor manufactured in Italy, is being voluntarily initiated by Amgen, Inc., the manufacturer of the medication.